Alexander Rudensky chairs the immunology program and directs the Ludwig Center for Cancer Immunotherapy at Memorial Sloan-Kettering Cancer Center (MSKCC) and is an investigator with the Howard Hughes Medical Institute.
Christopher Hunter, Ph.D., holds the Mindy Halikman Heyer President’s Distinguished Chair and chairs the Department of Pathobiology at the University of Pennsylvania School of Veterinary Medicine. His research focuses on cellular immune-system interactions.
Mats Wahlström has served on the company’s Board of Directors since January 2012. He is Chief Executive Officer and Chairman of KMG Capital Partners, LLC, and Chairman of PCI | HealthDev and Caduceus Medical Holdings, LLC.
Taofeek K. Owonikoko, MD, PhD, is Chief of the Division of Hematology/Oncology at UPMC Hillman Cancer Center and in the Department of Medicine. He is also Associate Director for Translational Research and Co-Leader of the Cancer Therapeutics Program at Hillman.
Coherus Oncology is a commercial-stage biopharma advancing next-generation combination therapies to elevate what’s possible for people living with cancer.
Coherus Oncology is a commercial-stage company advancing next-generation combination therapies to elevate what’s possible for people living with cancer.
